1. Introduction: The Cognitive Impact of Traumatic Brain Injury and the Promise of Deep Brain Stimulation

Traumatic brain injury (TBI) is a major global health concern, with over 69 million cases reported annually [1]

Figure 1: Global incidence and prevalence of traumatic brain injury compared with other common neurological diseases

Traumatic brain injuries (TBI) are the major cause of disability and deaths, burdening individuals, families, health systems and societies [2]

Figure 2. Hospital discharges and deaths due to TBI by age

These impairments range from difficulties with memory, attention, and executive function to slower processing speeds and problems with language [3]. For many TBI survivors, the cognitive deficits become a persistent barrier to resuming normal daily activities, returning to work, and maintaining relationships, leading to a reduced quality of life.

Figure 3: Simple schematic outlining the pathophysiological responses following traumatic brain injury and the complex outburst of secondary impairments. Note that secondary injury processes of traumatic brain injury (TBI) include blood–brain barrier (BBB) disruption, neuroinflammation, excitotoxicity, metabolic impairments, apoptosis, oxidative stress, ischemia, and others. Associated with BBB impairment, microglial and astrocyte activation, leukocyte infiltration, and upregulation of pro-inflammatory cytokines are characteristic of the neuroinflammatory response of TBI

Traumatic brain injury (TBI) represents a spectrum of micro- and macroscopic brain injury, traditionally classified as mild, moderate, or severe [4]. Yet, irrespective of the degree of injury, cognitive impairments remain a common and challenging outcome These deficits are not only disruptive to the individual’s daily life but also impose significant social and economic burdens on families and healthcare systems.[5] In the United States alone, TBI-related healthcare costs are estimated to reach over $76.5 billion annually, emphasizing the pressing need for effective therapeutic solutions [6]

Limitations of Current Treatment Strategies

Traditionally, the treatment of TBI-related cognitive impairments has relied on cognitive rehabilitation therapies, pharmacological interventions, and behavioral strategies.[7] Cognitive rehabilitation focuses on retraining the brain through tasks designed to improve attention, memory, and executive function, while pharmacotherapy aims to alleviate symptoms using medications such as stimulants and antidepressants [8] . However, while these interventions can offer some benefits, their overall efficacy in restoring lost cognitive function is often limited, particularly for patients with moderate to severe injuries [9]

One of the major limitations of current treatments is their inability to generalize improvements to real-world settings. Although patients may show progress in structured therapy sessions, these gains do not always translate to better performance in everyday life [10]. Moreover, pharmacotherapy is often associated with side effects that may exacerbate existing cognitive or emotional difficulties, making it a less ideal option for long-term use.[11]

This lack of effective treatment options highlights the urgent need for new therapeutic approaches that can address the complex and diverse cognitive challenges faced by TBI survivors. In recent years, neuromodulatory techniques, particularly deep brain stimulation (DBS), have garnered attention as potential game-changers in the field of cognitive rehabilitation for TBI [12].

Figure 4: A summary of key points discussed in the current narrative review.

Deep Brain Stimulation: A Novel Approach

Deep brain stimulation is a neurosurgical technique that has traditionally been used to treat movement disorders such as Parkinson’s disease.[13] It involves the implantation of electrodes into specific regions of the brain, which are then stimulated with electrical impulses to modulate neuronal activity [14]. Over time, researchers have expanded the scope of DBS to explore its potential in treating other neurological conditions, including depression, epilepsy, and, more recently, cognitive deficits following TBI [15]

DBS presents a promising opportunity for cognitive recovery after TBI, as it offers a targeted and modifiable method for enhancing neuroplasticity—the brain’s ability to reorganize and form new neural connections [16]. By stimulating key areas of the brain involved in cognition, such as the thalamus, hippocampus, and prefrontal cortex, DBS may help restore disrupted neural circuits and improve cognitive functions like memory, attention, and executive processing [17].

Preliminary studies have shown encouraging results, with some TBI patients experiencing significant improvements in cognitive function following DBS. Although these studies are in the early stages and involve small sample sizes, the potential for DBS to revolutionize TBI treatment is gaining recognition [18]

Figure 5: Different types of stimulation used in DoC patients. Schematic representation of the different types of invasive a non-invasive stimulation used in DoC patients. We listed the main targets and stimulation parameters (intensities, voltages, frequencies, and number of sessions) used in clinical studies. DBS, deep brain stimulation; Hz, Hertz; mA, milli-ampere; rTMS, rhythmic transcranial magnetic stimulation; tDCS, transcranial direct current stimulation; V, Volt; VNS, vagus nerve stimulation Future Prospects

As research into DBS for TBI progresses, it holds the promise of becoming a viable therapeutic option for individuals suffering from cognitive impairments.[19] The ability to fine-tune stimulation parameters, target specific brain regions, and integrate DBS with other rehabilitation strategies makes it a flexible and potentially transformative treatment [20]. While challenges remain, particularly in refining patient selection criteria and long-term safety, DBS offers a new frontier in the quest to improve the quality of life for TBI survivors.[21]

In this narrative review, we will explore the mechanisms, clinical evidence, and future directions of DBS as a therapeutic approach for cognitive recovery after TBI. By understanding the potential of DBS to modulate brain function and promote recovery, we hope to provide insights into its role as a critical tool in the evolving landscape of TBI rehabilitation.

2. Mechanisms of DBS in Cognitive Restoration: Rewiring the Injured Brain Precision Targeting: A Neuroscientific Approach to Recovery

Deep Brain Stimulation (DBS) operates on the principle that targeted electrical stimulation of specific brain regions can modulate dysfunctional neural circuits, potentially improving cognitive function.[22] DBS's efficacy in cognitive restoration, especially after traumatic brain injury (TBI), relies on an in-depth understanding of the brain’s neural architecture. The primary goal is to precisely target and modulate the brain circuits involved in key cognitive processes such as memory, attention, and executive function. By doing so, DBS can correct neural imbalances and enhance the brain’s ability to restore proper function.

The premise behind DBS as a therapy for cognitive restoration is that the brain’s neural circuits are plastic and capable of reorganization after injury[23]. Cognitive impairments resulting from TBI often arise from disruptions in these circuits. DBS, through precise electrical stimulation, seeks to recalibrate these circuits and improve communication between key brain regions.[24] Targeting specific areas with DBS allows for a nuanced and adaptable approach to rehabilitating cognitive function, as the stimulation parameters (frequency, intensity, duration) can be customized based on the individual’s needs.[25]

Figure 6: Deep Brain Stimulation for Alzheimer's and Parkinson's Diseases.

DBS not only affects the immediate area where the electrodes are placed but also has broader effects on brain networks—a process known as network modulation.[26] In TBI, cognitive deficits often arise from impaired communication between different regions of the brain, causing a breakdown in network connectivity. DBS can help re-establish balanced neural activity within these disrupted networks, improving the coordination and integration of cognitive processes.[27]

The brain operates as a complex network, where multiple regions communicate continuously to support cognitive functions. After a brain injury, this communication often becomes disorganized, leading to deficits in attention, memory, and executive function. DBS’s ability to modulate these networks offers a promising approach to restoring cognitive equilibrium. By enhancing the activity in one part of the network, DBS can influence broader regions and promote improved information flow, leading to more efficient cognitive processing.

In practical terms, DBS works by influencing key neural hubs that control cognitive functions. For instance, by stimulating the thalamus or prefrontal cortex, DBS can impact a wider network of regions involved in memory or decision-making.[28] This approach does not merely address localized dysfunction but aims to optimize the entire neural network responsible for cognitive integration.

I. Thalamus

The thalamus plays a pivotal role in the brain, functioning as a relay station for sensory, motor, and cognitive information. It integrates inputs from various brain regions and transmits them to the cortex, where higher-order processing occurs. [29] Crucially, the thalamus is involved in thalamocortical oscillations, which are essential for cognitive functions such as attention and executive control. Disruption in these oscillations, often seen in TBI, can lead to deficits in attention, information processing speed, and executive function.[30]

DBS of the thalamus has shown potential in improving these cognitive functions by modulating the oscillatory activity that underlies these processes. Specifically, thalamic DBS can enhance the signal-to-noise ratio, making neural communication between the thalamus and cortex more efficient.[31] As a result, attention and cognitive processing improve. Recent studies have demonstrated that restoring normal thalamocortical rhythms through DBS in TBI patients significantly enhances cognitive performance, particularly in areas like processing speed and attention. A 2023 phase 1 feasibility study indicated that thalamic DBS could enhance cognitive performance by improving thalamocortical synchronization and overall information processing efficiency (Thalamic Deep Brain Stimulation in Traumatic Brain Injury: A Phase 1, Randomized Feasibility Study, 2023).

The nucleus accumbens (NAc) plays a critical role in motivation, reward processing, and goal-directed behavior. In individuals with TBI, damage to this region can manifest as apathy, lack of motivation, and impaired goal-directed behavior.[32] These symptoms often stem from disruptions in the brain’s reward circuitry, which is closely linked to dopaminergic pathways. DBS targeting the NAc aims to restore motivation and reward-driven behaviors by modulating these pathways.

DBS of the NAc can help alleviate motivational deficits in TBI patients by enhancing dopaminergic signaling, which plays a central role in reward and motivational states. Research shows that stimulating the NAc improves goal-directed behaviors and reduces apathy, allowing patients to engage more fully in daily activities and rehabilitation efforts. [33] This ability to modulate motivational circuits is particularly important in TBI patients, who often struggle with initiating and sustaining actions necessary for cognitive and emotional recovery [34]

• Hippocampus: The hippocampus is central to memory formation, consolidation, and In TBI patients, memory deficits are common due to disruptions in hippocampal function.[35] DBS of the hippocampus holds promise for improving memory deficits by enhancing the processes of encoding and retrieval, key functions that the hippocampus governs. By modulating neural activity in this area, DBS may facilitate improved memory performance, particularly in tasks involving working memory and episodic memory.[36]

• Prefrontal Cortex (PFC): The prefrontal cortex is vital for executive functions such as planning, decision-making, and working memory. These higher-order cognitive processes often become impaired following a brain injury.[37] DBS targeting the PFC could improve these functions by modulating circuits responsible for executive control. Enhancements in PFC activity might lead to improved planning, better decision-making abilities, and increased cognitive flexibility, allowing individuals to better manage complex tasks and navigate daily life more effectively [38]

I. Modulation of Neuronal Activity

DBS exerts its effects by directly modulating neuronal firing patterns. This modulation can either increase or decrease the activity of neurons in the targeted area, depending on the stimulation parameters such as frequency and amplitude. For example, highfrequency stimulation tends to increase neuronal firing, while low-frequency stimulation can have an inhibitory effect. The ability to tailor these parameters allows DBS to correct abnormal firing patterns, which are often a hallmark of cognitive dysfunction following brain injury.

The modulation of neuronal activity helps recalibrate brain circuits, leading to improvements in cognitive function. By restoring appropriate firing rates, DBS can improve communication between neurons, thereby facilitating more efficient information processing and cognitive recovery [39].

Another crucial mechanism through which DBS operates is synaptic plasticity, the brain's ability to strengthen or weaken synaptic connections over time. Synaptic plasticity, specifically long-term potentiation (LTP) and long-term depression (LTD), underlies learning and memory.[40] DBS has been shown to promote LTP, enhancing synaptic strength in specific circuits, which can improve memory formation and learning in patients with TBI. Conversely, DBS can also induce LTD, which weakens synaptic connections and can help suppress maladaptive neural pathways that contribute to cognitive impairments.

Figure 7 Image 1: Priming mechanisms during wakefulness. (A) Individual neurons and synapses activated by two different experiences (1 [green] and 2 [purple]). Experience 1 activates synapses onto two different neurons, while Experience 2 activates different synapses on the same neuron. In this example, Experiences 1 and 2 will stimulate one common neuron and a subset of common synapses on the same dendritic branch. Experience will increase excitability in selected neurons (highlighted with red outline) and tag synapses positively (red cap on spines) or negatively (blue cap on spines). (B) Enlargement of the segment of dendrites outlined with an orange rectangle in (A). CREB activation and IEGs expression will be triggered in activated neurons. This leads to a transcription of Plasticity Related Products (PRPs: e.g., arc, bdnf, PSD-95, Homer1a) transported to dendrites. (C) Illustration of mechanisms of neuronal (left) and synaptic (right) priming. Neuronal priming is mainly supported by CREB-dependent increase in neuronal/dendritic excitability. Synaptic priming is achieved by tagging mechanisms such as posttranslational modifications of receptors, enzymes, and actin filaments.

This ability of DBS to promote synaptic plasticity is key to its success in facilitating cognitive restoration. By strengthening the appropriate neural connections and suppressing those that are dysfunctional, DBS can enhance network connectivity, thus supporting cognitive processes that have been compromised by injury [41]

The brain’s cognitive functions rely on synchronized oscillatory activity, or brainwave rhythms, across various regions. Disruptions in these rhythms, particularly in gamma and theta waves, are often linked to cognitive deficits in TBI patients. Gamma oscillations are involved in attention and sensory processing, while theta oscillations play a crucial role in memory consolidation.

DBS has the potential to normalize these oscillatory patterns, leading to improved cognitive performance. For example, DBS can modulate gamma oscillations, improving sensory processing and attention, while enhancing theta rhythms to facilitate better memory consolidation. By restoring these critical brainwave rhythms, DBS helps reestablish normal cognitive processing, enabling the brain to perform complex tasks more effectively.

3. Clinical Evidence: Navigating a Landscape of Promise and Uncertainty

In the realm of traumatic brain injury (TBI) recovery, Deep Brain Stimulation (DBS) has garnered attention as a potential therapeutic intervention for cognitive deficits.[42] Early case reports and small clinical trials have illuminated its promise, offering hope to patients and clinicians alike. These initial findings suggest that DBS may have the capacity to improve cognitive domains such as attention, working memory, and executive function in patients who have suffered severe TBI.

For instance, one notable case involved a patient with severe cognitive impairment following TBI, who underwent thalamic DBS. Over time, the patient demonstrated significant improvements in memory, decision-making, and attention. Other smallscale studies have similarly reported improvements in cognitive functioning, with some patients regaining abilities that had been significantly compromised due to their injuries. These findings, though preliminary, suggest that DBS can positively impact key areas of cognitive function that are often impaired in TBI.

However, while these early successes offer glimmers of hope, they come with critical caveats. The small sample sizes and heterogeneity of TBI patients in these studies limit the generalizability of the results. TBI is a highly individualized condition, with cognitive impairments varying widely depending on the location, severity, and nature of the injury. While DBS has shown potential, larger and more rigorously designed studies are necessary to confirm its efficacy and establish it as a viable treatment option for cognitive recovery in the broader TBI population.

Despite the promise of early case studies, there are several significant challenges that must be addressed before DBS can become a standardized treatment for cognitive recovery in TBI patients. These challenges are primarily methodological, encompassing issues like small sample sizes, patient variability, and the need for more standardized outcome measures.

The most pressing limitation of the current body of DBS research for cognitive recovery in TBI is the small sample sizes in existing studies. While case reports and small trials have provided valuable insights, they lack the statistical power needed to draw definitive conclusions. The limited number of participants in these studies makes it difficult to generalize the findings across the diverse TBI population. Larger trials, with greater patient numbers and more diverse cohorts, are crucial to substantiate the early positive findings of DBS for cognitive recovery. A well-designed randomized controlled trial (RCT) with sufficient statistical power would allow researchers to account for variability in patient outcomes and establish whether DBS can reliably improve cognitive function in TBI patients

TBI is a complex condition that manifests differently in each patient depending on the location, severity, and mechanism of injury. This heterogeneity poses a significant challenge when trying to determine which individuals will benefit most from DBS. Some patients may experience impairments in memory and executive function, while others might struggle more with attention and motivation. This variability makes it difficult to predict the specific outcomes of DBS, as the therapy might not be equally effective across all types of cognitive deficits.

As a result, the development of personalized DBS protocols may be necessary to optimize treatment outcomes. By tailoring stimulation parameters to the unique neural and cognitive profiles of each patient, clinicians could enhance the efficacy of DBS. Advances in neuroimaging and electrophysiology may provide the tools needed to personalize DBS in this way, allowing for targeted stimulation that addresses the specific neural circuits affected by TBI.

Another challenge in the current research landscape is the lack of consistent and standardized outcome measures. Different studies use various cognitive assessment tools, making it difficult to compare results across trials. Some studies focus on specific cognitive domains, such as memory or attention, while others take a more global approach to measuring cognitive function.

To effectively evaluate the efficacy of DBS, it is essential to establish standardized and validated cognitive tests that can be used across studies. This would allow for more accurate comparisons of results and provide clearer evidence of DBS's impact on cognitive recovery. Additionally, standardized measures would help to refine DBS protocols by identifying which aspects of cognition are most responsive to stimulation.

Placebo effects are a well-known challenge in clinical research, and DBS studies are no exception. Addressing placebo effects through well-designed sham-controlled trials is crucial to ensure that observed improvements are genuinely due to DBS and not psychological factors or patient expectations. In DBS trials, sham controls typically involve implanting electrodes without activating the stimulation, allowing researchers to isolate the true effects of DBS from any placebo responses.[43]

Blinding, where feasible, is essential in these trials. While patients may find it difficult to remain unaware of whether their DBS is active, careful study design can help minimize bias. Incorporating sham control groups and maintaining blinding in analyses will strengthen the validity of future DBS studies.

One of the primary concerns with DBS research is the lack of long-term follow-up in many existing studies. While short-term improvements in cognitive function have been reported, it is unclear whether these effects persist over time. Cognitive recovery is a dynamic process, and the long-term durability of DBS-induced improvements remains a critical question.[44]

To fully understand the potential of DBS for cognitive recovery, studies must include longer follow-up periods, ideally tracking patients for several years after treatment. This would provide insight into the longevity of DBS’s effects and whether additional interventions or adjustments to the stimulation protocol are necessary to maintain cognitive improvements over time.

In recent years, several clinical trials have been launched to address the limitations of earlier studies and explore the full potential of DBS for cognitive recovery in TBI patients. These trials incorporate larger sample sizes, more rigorous designs, and longer follow-up periods, offering the potential for more definitive conclusions about DBS’s efficacy.

For example, a multi-center randomized controlled trial is currently investigating the effects of DBS on cognitive deficits related to TBI, with a focus on both short-term and long-term outcomes. Preliminary results from these larger studies are expected in the coming years, which will help clarify the role of DBS in cognitive recovery and determine which patients are most likely to benefit from the intervention.[45]

One of the most exciting developments in the field of DBS is the emergence of closedloop systems. [46]Traditional DBS delivers continuous stimulation, but closed-loop systems offer a more dynamic approach, adjusting stimulation parameters in real time based on the patient’s brain activity. This technology uses feedback loops to monitor neural signals and optimize stimulation, potentially improving efficacy while reducing side effects.[47]

Closed-loop DBS could be particularly beneficial for TBI patients, as it allows for more precise modulation of neural circuits that are disrupted by injury. By responding to fluctuations in brain activity, closed-loop systems may enhance cognitive recovery while minimizing the risk of overstimulation or other adverse effects.

Figure 8: Image 1. Schematic diagram of cortical basal ganglia network model. (A) Network diagram of cortical basal ganglia neuron populations. Excitatory and inhibitory synaptic connections within the network are represented as solid red arrow and blue dotted arrows, respectively. (B) Electric field distribution due to monopolar stimulation electrode. Cortical collaterals, represented as black dots, are oriented perpendicular to the page. The electrode bipolar recording contacts are represented by + and –, respectively. (C) Schematic diagram of the closed-loop stimulator utilizing an LFP derived measured of network beta-band activity. Contacts 1 and 3 represent the bipolar recording electrode contacts on the DBS electrode. The recorded LFP is bandpass filtered, rectified and averaged to calculate the average rectified value of the LFP beta-band activity. The beta average rectified value is used as input to a controller which determines an updated value for the DBS parameter being modulated. The updated DBS waveform is subsequently simulated at electrode contact 2 and varies the electric field distribution.

Research is also underway to identify biomarkers that can predict a patient’s response to DBS. These biomarkers could include neuroimaging markers, electrophysiological signatures, or even blood-based indicators of neural health. Identifying reliable biomarkers would enable clinicians to personalize DBS treatment by selecting patients who are most likely to benefit from the therapy.[48]

Biomarkers could also help refine DBS protocols by providing real-time feedback on the brain’s response to stimulation. This would allow for more precise targeting of neural circuits and better outcomes for patients undergoing DBS for cognitive recovery.[49]

Figure 9: The success of closed-loop DBS in such settings will depend on the identification of symptom-specific biomarkers, which ideally should reflect causal mechanisms of the underlying pathology

Finally, combining DBS with other therapeutic interventions, such as cognitive rehabilitation or pharmacotherapy, may offer a more comprehensive approach to TBI recovery. While DBS can modulate neural circuits to improve cognitive function, integrating it with cognitive rehabilitation programs could further enhance recovery by reinforcing the neural changes induced by stimulation.

Pharmacological interventions, such as medications that enhance neuroplasticity, may also complement DBS by creating a more favorable environment for cognitive recovery.[50] This multi-modal approach could address the diverse and complex symptoms of TBI more effectively than any single therapy alone

Figure 10: Schematic representation of TMS and DBS coupling and its potential advantages. DBS: deep brain stimulation; GPe: external globus pallidus; GPi: globus pallidus internus; LFPs: local field potentials; PAS: paired associative stimulation; TMS: transcranial magnetic stimulation; STN: subthalamic nucleus. The figure was created by V.D. with Inkscape (version 1.2.2).

4. DBS Beyond Cognition: A Holistic Approach to TBI Recovery

Traumatic brain injury (TBI) is a multifaceted condition that affects not only cognitive functions but also motor abilities, mood, and emotional well-being.[51] As research continues to explore the potential of Deep Brain Stimulation (DBS) in treating the cognitive deficits associated with TBI, a more comprehensive approach has emerged— one that looks beyond cognition. DBS, a neuromodulation therapy that delivers electrical impulses to targeted areas of the brain, shows promise in addressing a wide range of symptoms that TBI survivors face, offering hope for a more holistic recovery.

The impact of TBI extends far beyond cognitive impairment. Many survivors struggle with motor dysfunction, mood disorders, and emotional dysregulation, which can severely impact their ability to lead fulfilling and independent lives [52]. Given the complexity of TBI, it is increasingly clear that treatment must be equally multifaceted. DBS offers a potential solution by targeting multiple brain networks involved in these varied functions, helping to alleviate not only cognitive deficits but also motor and emotional symptoms. By modulating neural circuits associated with different brain functions, DBS may support a more comprehensive recovery for TBI patients.[53]

Motor impairments are a common and often debilitating consequence of TBI.[54] These impairments can manifest as spasticity, tremors, gait disturbances, and other movement disorders that reduce mobility and interfere with daily activities. For many TBI survivors, the loss of motor function means losing the ability to perform basic selfcare tasks, which undermines their independence and quality of life. DBS has shown potential in addressing these motor deficits, especially when targeted at brain regions involved in motor control, such as the subthalamic nucleus and globus pallidus.

Several case studies and small trials have reported improvements in motor function following DBS treatment in TBI patients. By improving motor control and reducing symptoms like spasticity and tremors, DBS may enhance a patient’s ability to move more freely and regain some level of independence. For instance, individuals who previously relied on caregivers for everyday activities may be able to resume walking, dressing, or feeding themselves after DBS treatment. These functional improvements can have a profound impact on a patient’s overall well-being, offering them not just physical recovery, but a renewed sense of autonomy.

Mood and behavioral challenges, including depression, anxiety, irritability, and emotional dysregulation, are common in TBI survivors. [55]These challenges can be as disabling as the cognitive and motor impairments, leading to social isolation, difficulty maintaining relationships, and a diminished quality of life. Traditional treatments, such as medication and psychotherapy, may offer limited relief, especially when emotional dysregulation is rooted in the brain’s disrupted neural circuits. This is where DBS presents a novel opportunity.

DBS has been explored as a treatment for various mood disorders, with promising results in TBI patients. Targeting areas of the brain involved in emotional regulation, such as the nucleus accumbens and amygdala, DBS may help stabilize mood and reduce symptoms of depression and anxiety. In some cases, patients have reported not only a decrease in negative emotions but also an improvement in overall emotional well-being, allowing them to engage more fully in social activities and daily life.

Additionally, DBS may help mitigate irritability and aggression, which are common behavioral issues in TBI patients. By modulating circuits that control emotional responses, DBS can lead to a more balanced emotional state, which in turn may improve interpersonal relationships and reduce the burden on caregivers. As TBI survivors often struggle with frustration and impulsivity, these improvements in emotional regulation can significantly enhance their social functioning and overall quality of life.

Given the highly individualized nature of TBI, a one-size-fits-all approach to DBS treatment is unlikely to be effective. The severity and location of brain injury, the type of cognitive and motor impairments, and the patient’s overall medical history all influence the potential outcomes of DBS therapy. To maximize the benefits of DBS, personalized treatment approaches are being developed, which involve tailoring the stimulation parameters to each patient’s unique needs.

Personalized DBS relies on advances in brain mapping and neuroimaging, which allow clinicians to better understand the specific neural circuits affected by a patient’s injury.[56] For example, brain mapping can identify the precise regions responsible for a patient’s motor or cognitive deficits, enabling targeted stimulation. This precision can increase the effectiveness of DBS while minimizing side effects, such as overstimulation or adverse emotional responses. In some cases, real-time feedback mechanisms can be integrated into DBS systems to adjust the stimulation based on the brain’s immediate responses, further optimizing the therapy for each patient.

Moreover, personalized DBS could also extend to addressing specific mood and behavioral challenges. For example, if a patient is struggling primarily with depression or anxiety, the stimulation could be directed toward brain areas associated with emotional regulation, while those with motor impairments could receive stimulation in regions responsible for movement control. This individualized approach allows for more focused interventions that target the most debilitating aspects of a patient’s TBI, ultimately improving outcomes.

As DBS research continues to evolve, there is growing recognition that combining DBS with other therapies could further enhance recovery for TBI patients. A multi-modal approach, which integrates DBS with cognitive rehabilitation, physical therapy, and pharmacological interventions, holds significant potential. For example, combining DBS with cognitive rehabilitation programs could reinforce the neural changes induced by stimulation, enhancing improvements in memory, attention, and executive function. Likewise, physical therapy could work synergistically with DBS to improve motor function, while medications that promote neuroplasticity may create a more favorable environment for cognitive and emotional recovery.

The goal of a multi-modal approach is to address the diverse symptoms of TBI in a more comprehensive manner. By targeting multiple aspects of the injury simultaneously, this approach could provide more substantial and long-lasting improvements, offering patients a clearer path toward recovery

5. Conclusion Illuminating the Path to Cognitive Recovery

As research into traumatic brain injury (TBI) recovery progresses, Deep Brain Stimulation (DBS) is emerging as a groundbreaking therapeutic tool. For decades, the cognitive, emotional, and motor deficits caused by severe TBI have posed significant challenges to both patients and healthcare providers. Many of these impairments have proven resistant to conventional treatments, leaving patients with long-lasting disabilities that affect their quality of life. DBS offers a glimmer of hope in this difficult landscape, providing new avenues for improvement in areas previously considered untreatable. Although DBS is not a cure, it represents a major step forward in enhancing cognitive function, emotional well-being, and motor recovery in TBI patients, signaling a paradigm shift in how we approach TBI treatment.

DBS: A Paradigm Shift in TBI Treatment

For TBI patients, particularly those with severe impairments, DBS marks a turning point in therapeutic interventions. Traditional treatments for TBI have primarily focused on rehabilitation through physical therapy, cognitive training, and, in some cases, pharmacotherapy. While these treatments can be effective for some patients, many TBI survivors experience persistent deficits that severely limit their ability to function independently, manage emotions, or return to their pre-injury lives. DBS, by targeting specific brain regions responsible for cognitive, motor, and emotional processes, represents a significant departure from these conventional methods. It shifts the focus from symptomatic management to directly modulating the neural circuits affected by the injury.DBS has already demonstrated success in improving cognitive functions such as attention, memory, and executive function in patients with severe TBI. This neuromodulation technique has also shown promise in addressing motor impairments, such as tremors and spasticity, and improving mood disorders, such as depression and anxiety. For many patients, DBS has offered a new level of cognitive clarity, emotional stability, and motor control that seemed unreachable with traditional therapies alone. This multi-faceted impact makes DBS a compelling option for addressing the complex, interconnected symptoms of TBI.

One of the most promising aspects of DBS is its potential to be personalized to each patient's unique needs. TBI manifests differently depending on the location, severity, and nature of the injury, and no two patients have exactly the same profile of impairments. DBS allows clinicians to tailor treatment by targeting the specific brain networks most affected by the injury. Whether the focus is on restoring cognitive function, improving motor control, or regulating mood, DBS offers the flexibility needed to address the varied symptoms of TBI in a way that conventional therapies cannot.

However, despite its early successes, DBS is not a universal solution, and there are significant challenges to its widespread adoption. DBS represents a paradigm shift not just in the treatment of TBI but in the understanding of how brain injuries can be managed. As such, its implementation requires a careful and thoughtful approach, particularly as we continue to learn more about the long-term effects of neuromodulation in TBI patients.

Bridging the Research-Practice Gap: A Call to Action

While the promise of DBS in TBI treatment is evident, much work remains to be done before it can become a mainstream therapeutic option. The gap between early research findings and widespread clinical application is substantial, and closing this gap will require ongoing collaboration between researchers, clinicians, engineers, and other stakeholders. Only through multidisciplinary efforts can we fully realize the potential of DBS for TBI recovery.

Larger Clinical Trials and Rigorous Research

One of the most critical steps toward making DBS a viable treatment option for a broader TBI population is conducting larger, more rigorous clinical trials. While early case studies and small-scale trials have shown encouraging results, the small sample sizes and heterogeneity of TBI patients limit the generalizability of these findings. TBI is a highly individualized condition, and what works for one patient may not work for another. Larger randomized controlled trials (RCTs) with diverse patient populations are necessary to confirm the efficacy of DBS across different types of brain injuries and to refine treatment protocols. These studies should also include long-term follow-up to determine the durability of DBS-induced improvements, as TBI recovery is a dynamic process that unfolds over time.

Ethical Considerations and Patient Selection

As with any novel medical intervention, the use of DBS in TBI patients raises important ethical questions. One key issue is patient selection: how do we determine which patients are most likely to benefit from DBS? Not all TBI survivors will be suitable candidates for the procedure, and the risks associated with brain surgery must be carefully weighed against the potential benefits. Neuroimaging biomarkers, electrophysiological data, and detailed neuropsychological assessments may help identify the patients most likely to respond positively to DBS. However, it is essential to ensure that these selection processes are transparent, fair, and based on the best available evidence.

Additionally, informed consent is a critical ethical consideration in the use of DBS for TBI. Patients and their families must be fully informed about the potential risks, benefits, and uncertainties associated with the procedure. Given the invasive nature of DBS, it is crucial that patients understand the long-term commitment required, including the need for regular follow-up appointments, potential adjustments to the stimulation parameters, and ongoing monitoring for side effects.

Long-Term Monitoring and Safety

Long-term monitoring will play a vital role in ensuring the safe and effective implementation of DBS for TBI recovery. While short-term studies have reported improvements in cognitive, motor, and emotional functions, it remains unclear how long these benefits last and whether the stimulation may need to be adjusted over time. Cognitive recovery is not a static process, and patients' needs may change as they continue to heal and adapt to their injuries. Therefore, long-term follow-up is essential to determine the sustainability of DBS's effects and to monitor for any potential side effects, such as overstimulation or changes in mood.

As research advances, the development of closed-loop DBS systems, which adjust stimulation in real time based on the patient's brain activity, may provide a more responsive and personalized approach. These systems could help minimize side effects while maximizing the therapeutic benefits of DBS, offering a safer and more effective treatment option for TBI patients

References

1. Koome G, Thuita F, Egondi T, et al., Association between traumatic brain injury (TBI) patterns and mortality: a retrospective case-control study. F1000Research 10 (2022): 795.
2. Matney C, Bowma, K, Berwick D. The scope and burden of traumatic brain injury. Traumatic Brain Injury - NCBI Bookshelf. (2022).
3. Pugh MJ, Kennedy E, Prager EM, et al., Phenotyping the Spectrum of Traumatic Brain Injury: A Review and Pathway to Standardization. Journal of Neurotrauma 38 (2021): 3222–3234.
4. Liu T, Yu S, Liu M, et al.,Cognitive impairment in Chinese traumatic brain injury patients: from challenge to future perspectives. Frontiers in Neuroscience 18 (2024).
5. Shen J, Shi J, Cooper J, et al., A Population- Based study of the incidence, medical care, and medical expenditures for Pediatric Traumatic Brain injury. Journal of Surgical Research 268 (2021): 87–96.
6. Caixeta L, Caixeta VM. Therapeutic synergism: How can psychopharmacology improve cognitive rehabilitation? Dementia & Neuropsychologia 13 (2019): 422–426.
7. Woods B, Rai HK, Elliott E, et al., Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Library, 2023 (1).
8. Webb CA, Cohen ZD, Beard C, et al., Personalized prognostic prediction of treatment outcome for depressed patients in a naturalistic psychiatric hospital setting: A comparison of machine learning approaches. Journal of Consulting and Clinical Psychology 88 (2020): 25–38.
9. Hnatešen D, Radoš I, Dimitrijevic I, et al., Influence of the Cognitive and Emotional Status of Patients with Chronic Pain on Treatment Success (Reduction in Pain Intensity and Adherence to Pharmacotherapy): A Prospective Study. International Journal of Environmental Research and Public Health, 19 (2022): 15968.
10. Popa LL, Chira D, Strilciuc S, et al., Non-Invasive Systems application in traumatic brain injury rehabilitation. Brain Sciences, 13 (2023): 1594.
11. Deep brain stimulation. (2021, August 8). Johns Hopkins Medicine.
12. Lozano AM, Lipsman N, Bergman H, Deep brain stimulation: current challenges and future directions. Nature Reviews Neurology 15 (2019): 148–160.
13. Zotey V, Andhale A, Shegekar T, Juganavar A. Adaptive Neuroplasticity in Brain injury recovery: Strategies and Insights. Cureus (2023).
14. Tiefenbach J, Chan HH, Machado AG, et al., Neurostimulation for functional recovery after Traumatic Brain injury: Current evidence and future directions for invasive surgical approaches. Neurosurgery 91 (2022): 823–830.
15. McNerney MW, Gurkoff GG, Beard C, et al., The rehabilitation potential of neurostimulation for mild traumatic brain injury in animal and human studies. Brain Sciences, 13 (2023): 1402.
16. Maas AIR., Menon DK, Manley GT, et al., Traumatic brain injury: progress and challenges in prevention, clinical care, and research. The Lancet Neurology, 21 (2022): 1004–1060.
17. Kai TSZ, Man-Lung F, Junhao K, The paradoxical effect of deep brain stimulation on memory. Aging and Disease, 11 (2020): 179.
18. Kricheldorff, J., Göke, K., Kiebs, M., Kasten, F. H., Herrmann, C. S., Witt, K., & Hurlemann, R. (2022). Evidence of Neuroplastic Changes after Transcranial Magnetic, Electric, and Deep Brain Stimulation. Brain Sciences, 12(7), 929.
19. Xu W, Wang J, Li X, et al., Neuronal and synaptic adaptations underlying the benefits of deep brain stimulation for Parkinson’s disease. Translational Neurodegeneration, 12 (2023).
20. Hamani C, Davidson B, Lipsman N, et al., Insertional effect following electrode implantation: an underreported but important phenomenon. Brain Communications 6 (2024).
21. Khalife MR, Scott RC, Hernan AE. Mechanisms for cognitive impairment in epilepsy: Moving beyond seizures. Frontiers in Neurology, 13 (2022).
22. Widge AS, Zorowitz S, Basu I, et al., Deep brain stimulation of the internal capsule enhances human cognitive control and prefrontal cortex function. Nature Communications 10 (2019).
23. Professional CCM. Thalamus. Cleveland Clinic. (2024).
24. Filchenko I, Bassetti CLA, Herrera CG. Thalamic Stroke: an opportunity to study the brain mechanisms of Sleep–Wake and cognition. Clinical and Translational Neuroscience 7 (2023): 36.
25. Xu Y, Lin Y, Yu M, et al., The nucleus accumbens in reward and aversion processing: insights and implications. Frontiers in Behavioral Neuroscience 18 (2024).
26. Aronson JP, Katnani HA, Huguenard A, et al., Phasic stimulation in the nucleus accumbens enhances learning after traumatic brain injury. Cerebral Cortex Communications 3 (2022b).
27. Palmisano S, Fasotti L, Bertens D. Neurobehavioral initiation and motivation problems after acquired brain injury. Frontiers in Neurology 11 (2020).
28. Roux C, Leger M, Freret T. Memory Disorders related to hippocampal Function: The interest of 5-HT4Rs targeting. International Journal of Molecular Sciences 22 (2021): 12082.
29. Mankin EA, Fried I. Modulation of human memory by deep brain stimulation of the Entorhinal-Hippocampal circuitry. Neuron 106 (2020): 218–235.
30. Friedman NP, Robbins TW. The role of prefrontal cortex in cognitive control and executive function. Neuropsychopharmacology, 47 (2021): 72–89.
31. Wang D, Marcantoni E, Clouter A, et al., Rhythmic sensory stimulation as a noninvasive tool to study plasticity mechanisms in human episodic memory. Current Opinion in Behavioral Sciences, 58 (2024): 101412.
32. Farokhniaee A, McIntyre CC. Theoretical principles of deep brain stimulation induced synaptic suppression. Brain Stimulation 12 (2019): 1402–1409.
33. Deep brain stimulation improves cognition during chronic recovery phase of brain injury. (n.d.). WCM Newsroom.
34. Burke MJ, Kaptchuk TJ, Pascual-Leone A. Challenges of differential placebo effects in contemporary medicine: The example of brain stimulation. Annals of Neurology 85 (2019): 12–20.
35. Unadkat P, Quevedo J, Soares J. Opportunities and challenges for the use of deep brain stimulation in the treatment of refractory major depression. Discover Mental Health, 4 (2024).
36. Wang J, Pan R, Cui Y, Effects of deep brain stimulation in the subthalamic nucleus on neurocognitive function in patients with Parkinson’s Disease compared with medical therapy: A Meta-Analysis. Frontiers in Neurology 12 (2021).
37. Cuschieri A, Borg N, & Zammit, C. (2022). Closed loop deep brain stimulation: A systematic scoping review. Clinical Neurology and Neurosurgery 223 (2022): 107516.
38. Prosky, J., Cagle, J., Sellers, K. K., Gilron, R., De Hemptinne, C., Schmitgen, A., Starr, P. A., Chang, E. F., & Shirvalkar, P. (2021). Practical Closed-Loop Strategies for Deep Brain Stimulation: Lessons from Chronic pain. Frontiers in Neuroscience, 15.
39. Peeters, J., Boogers, A., Van Bogaert, T., Dembek, T. A., Gransier, R., Wouters, J., Vandenberghe, W., De Vloo, P., Nuttin, B., & Laughlin, M. M. (2023). Towards biomarker-based optimization of deep brain stimulation in Parkinson’s disease patients. Frontiers in Neuroscience, 16. https://doi.org/10.3389/fnins.2022.1091781
40. Krauss, J. K., Lipsman, N., Aziz, T., Boutet, A., Brown, P., Chang, J. W., Davidson, B., Grill, W. M., Hariz, M. I., Horn, A., Schulder, M., Mammis, A., Tass, P. A., Volkmann, J., & Lozano, A. M. (2020). Technology of deep brain stimulation: current status and future directions. Nature Reviews Neurology, 17(2), 75–87.
41. Kumar J, Patel T, Sugandh F, et al., Innovative Approaches and Therapies to Enhance Neuroplasticity and Promote Recovery in Patients with Neurological Disorders: A Narrative Review. Cureus (2023).
42. Traumatic Brain Injury (TBI). (n.d.). National Institute of Neurological Disorders and Stroke.
43. Howlett JR, Nelson LD, Stein MB. Mental health consequences of traumatic brain injury. Biological Psychiatry, 91 (2022): 413–420.
44. Lynch DG, Narayan RK, Li Multi-Mechanistic Approaches to the Treatment of Traumatic Brain Injury: A review. Journal of Clinical Medicine 12 (2023): 2179.
45. Corrigan F., Wee IC, Collins-Praino LE. Chronic motor performance following different traumatic brain injury severity—A systematic review. Frontiers in Neurology, 14 (2023).
46. Robert S. Traumatic brain injury and mood disorders. Mental Health Clinician, 10(2020), 335–345.